Literature DB >> 8104066

Sex differences among recipients of benzodiazepines in Dutch general practice.

F W van der Waals1, J Mohrs, M Foets.   

Abstract

OBJECTIVE: To analyse sex differences among recipients of benzodiazepines in Dutch general practice.
DESIGN: Study of consultations and associated interventions as recorded in the Dutch national survey of general practice.
SETTING: Practices of 45 general practitioners monitored during 1 April to 30 June 1987.
SUBJECTS: 61,249 patients (29,035 (47.4%) men in the age groups 19-44, 45-64, and 65 years and over. MAIN OUTCOME MEASURES: Symptoms among recipients of repeat as well as new benzodiazepine prescriptions stratified by sex and age.
RESULTS: Prescriptions for benzodiazepines were found to be significantly more common among women than among men, (a) after correcting for the sex distribution of the total patient population, and (b) in the two oldest age groups after correcting for the number of consultations. Of all prescriptions for benzodiazepines, 89% (6055/6777) were repeats and 70% (4759/6777) requests. Only 9% (439/4759) of these were authorized by the general practitioner, the rest being issued by the general practitioner's assistant after he or she had referred to the diagnosis in the patient's record. In contrast, only three (1%) of the 492 first time recipients of benzodiazepines had requested a prescription and were not seen by the general practitioner. Women (43/96; 45%) aged 45-64 years received their first prescription for benzodiazepines almost twice as often as men (15/63; 24%) without symptoms or a diagnosis being an indication (female to male relative risk 1.88 (95% confidence interval 1.15 to 3.08)).
CONCLUSIONS: The sex difference among first time recipients of benzodiazepines seems to be due to general practitioners being less stringent when prescribing this drug for women. The difference continues in repeat prescriptions, physicians failing to check adequately the need for these.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104066      PMCID: PMC1678235          DOI: 10.1136/bmj.307.6900.363

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Patients, prescribing, and benzodiazepines.

Authors:  L Nolan; K O'Malley
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Cross-national study of the extent of anti-anxiety-sedative drug use.

Authors:  M B Balter; J Levine; D I Manheimer
Journal:  N Engl J Med       Date:  1974-04-04       Impact factor: 91.245

3.  Anti-anxiety agents: duration of use and characteristics of users in the U.S.A.

Authors:  G D Mellinger; M B Balter; E H Uhlenhuth
Journal:  Curr Med Res Opin       Date:  1984       Impact factor: 2.580

4.  General practice patients on long-term psychotropic drugs. A controlled investigation.

Authors:  J Catalan; D H Gath; A Bond; G Edmonds; P Martin; J Ennis
Journal:  Br J Psychiatry       Date:  1988-03       Impact factor: 9.319

Review 5.  Abuse liability of benzodiazepines.

Authors:  J H Woods; J L Katz; G Winger
Journal:  Pharmacol Rev       Date:  1987-12       Impact factor: 25.468

6.  Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home.

Authors:  K Morgan; H Dallosso; S Ebrahim; T Arie; P H Fentem
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

7.  A cross-national comparison of anti-anxiety/sedative drug use.

Authors:  M B Balter; D I Manheimer; G D Mellinger; E H Uhlenhuth
Journal:  Curr Med Res Opin       Date:  1984       Impact factor: 2.580

8.  Prevalence and correlates of the long-term regular use of anxiolytics.

Authors:  G D Mellinger; M B Balter; E H Uhlenhuth
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

9.  Health of long term benzodiazepine users.

Authors:  E K Rodrigo; M B King; P Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27
  9 in total
  17 in total

Review 1.  The policy implications of gender mainstreaming for healthcare research in the EU.

Authors:  Ineke Klinge; Peggy Maguire
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.

Authors:  R van Hulten; H G Leufkens; A Bakker
Journal:  Pharm World Sci       Date:  1998-04

3.  The gender gap in mental health service use.

Authors:  E Pattyn; M Verhaeghe; P Bracke
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-03-19       Impact factor: 4.328

4.  Debating benzodiazepine use.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1995-08       Impact factor: 3.275

5.  Sex differences among recipients of benzodiazepines.

Authors:  H Habraken; K Soenen
Journal:  BMJ       Date:  1993-10-23

6.  Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women.

Authors:  Shanna Babalonis; Joshua A Lile; Catherine A Martin; Thomas H Kelly
Journal:  Psychopharmacology (Berl)       Date:  2011-02-25       Impact factor: 4.530

7.  Prescription medications in Manitoba children: are there regional differences?

Authors:  Anita L Kozyrskyj
Journal:  Can J Public Health       Date:  2002 Nov-Dec

8.  The impact of hospitalisation on the initiation and long-term use of benzodiazepines.

Authors:  Rutger Stuffken; Rolf P van Hulten; Eibert R Heerdink; Kris L L Movig; Antoine C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2005-05-14       Impact factor: 2.953

9.  Determinants of chronic benzodiazepine use in the elderly: a longitudinal study.

Authors:  Hendrika J Luijendijk; Henning Tiemeier; Albert Hofman; Jan Heeringa; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

10.  Retrospective case series analysis of characteristics and trends in unintentional pharmaceutical drug poisoning by methadone, opioid analgesics, antidepressants and benzodiazepines in Clark County, NV 2009-13.

Authors:  Tamara Bruno; Jennifer R Pharr
Journal:  J Public Health (Oxf)       Date:  2017-06-01       Impact factor: 2.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.